Session

Pancreatic cancer clinical (Posters)

PREDICTIONS AND PREVENTING OF POSTOPERATIVE PANCREATIC FISTULA IN PATIENTS FOLLOWING PANCREATICODUODENECTOMY
PREDICTIONS AND PREVENTING OF POSTOPERATIVE PANCREATIC FISTULA IN PATIENTS FOLLOWING PANCREATICODUODENECTOMY

CHANGES OF ORAL AND DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE POSSIBLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS
CHANGES OF ORAL AND DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE POSSIBLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS

PANCREATIC CANCER SCREENING IN HIGH-RISK INDIVIDUALS
PANCREATIC CANCER SCREENING IN HIGH-RISK INDIVIDUALS

UTILITY OF HISTOPATHOLOGICAL REVISION IN THE MANAGEMENT OF GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASIA
UTILITY OF HISTOPATHOLOGICAL REVISION IN THE MANAGEMENT OF GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASIA

DIAGNOSTIC ACCURACY AND SAFETY OF ENDOSCOPIC ULTRASOUND BASED CONFOCAL LASER ENDOMICROSCOPY FOLLOWED BY THROUGH-THE-NEEDLE MICROFORCEPS BIOPSY IF REQUIRED FOR PATIENTS WITH INDETERMINATE PANCREATIC CYSTIC LESIONS
DIAGNOSTIC ACCURACY AND SAFETY OF ENDOSCOPIC ULTRASOUND BASED CONFOCAL LASER ENDOMICROSCOPY FOLLOWED BY THROUGH-THE-NEEDLE MICROFORCEPS BIOPSY IF REQUIRED FOR PATIENTS WITH INDETERMINATE PANCREATIC CYSTIC LESIONS

BODY COMPOSITION PARAMETERS AS SURVIVAL PREDICTORS IN PATIENTS WITH PANCREATIC CANCER – A RETROSPECTIVE MULTICENTER ANALYSIS
BODY COMPOSITION PARAMETERS AS SURVIVAL PREDICTORS IN PATIENTS WITH PANCREATIC CANCER – A RETROSPECTIVE MULTICENTER ANALYSIS

LOW SERUM VITAMIN D3 AND FECAL ELASTASE LEVELS ARE MARKERS OF DECREASED SURVIVAL IN PATIENTS WITH PANCREATIC CANCER
LOW SERUM VITAMIN D3 AND FECAL ELASTASE LEVELS ARE MARKERS OF DECREASED SURVIVAL IN PATIENTS WITH PANCREATIC CANCER

SYNCHRONOUS PREMALIGNANT LESIONS IN PATIENTS WITH PANCREATOBILIARY CANCERS
SYNCHRONOUS PREMALIGNANT LESIONS IN PATIENTS WITH PANCREATOBILIARY CANCERS

SURVIVAL AFTER RESECTION OF PANCREATIC CANCER ASSOCIATED WITH PANCREATIC CYSTIC NEOPLASM: NATIONWIDE REGISTRY-BASED STUDY
SURVIVAL AFTER RESECTION OF PANCREATIC CANCER ASSOCIATED WITH PANCREATIC CYSTIC NEOPLASM: NATIONWIDE REGISTRY-BASED STUDY

SURVIVAL AFTER RESECTION OF PANCREATIC CANCER ASSOCIATED WITH PANCREATIC CYSTIC NEOPLASM: NATIONWIDE REGISTRY-BASED STUDY
SURVIVAL AFTER RESECTION OF PANCREATIC CANCER ASSOCIATED WITH PANCREATIC CYSTIC NEOPLASM: NATIONWIDE REGISTRY-BASED STUDY

Pancreatic cancer clinical (Posters)  et al.

SYNCHRONOUS PREMALIGNANT LESIONS IN PATIENTS WITH PANCREATOBILIARY CANCERS
SYNCHRONOUS PREMALIGNANT LESIONS IN PATIENTS WITH PANCREATOBILIARY CANCERS

Pancreatic cancer clinical (Posters)  et al.

LOW SERUM VITAMIN D3 AND FECAL ELASTASE LEVELS ARE MARKERS OF DECREASED SURVIVAL IN PATIENTS WITH PANCREATIC CANCER
LOW SERUM VITAMIN D3 AND FECAL ELASTASE LEVELS ARE MARKERS OF DECREASED SURVIVAL IN PATIENTS WITH PANCREATIC CANCER

Pancreatic cancer clinical (Posters)  et al.

BODY COMPOSITION PARAMETERS AS SURVIVAL PREDICTORS IN PATIENTS WITH PANCREATIC CANCER – A RETROSPECTIVE MULTICENTER ANALYSIS
BODY COMPOSITION PARAMETERS AS SURVIVAL PREDICTORS IN PATIENTS WITH PANCREATIC CANCER – A RETROSPECTIVE MULTICENTER ANALYSIS

Pancreatic cancer clinical (Posters)  et al.

DIAGNOSTIC ACCURACY AND SAFETY OF ENDOSCOPIC ULTRASOUND BASED CONFOCAL LASER ENDOMICROSCOPY FOLLOWED BY THROUGH-THE-NEEDLE MICROFORCEPS BIOPSY IF REQUIRED FOR PATIENTS WITH INDETERMINATE PANCREATIC CYSTIC LESIONS
DIAGNOSTIC ACCURACY AND SAFETY OF ENDOSCOPIC ULTRASOUND BASED CONFOCAL LASER ENDOMICROSCOPY FOLLOWED BY THROUGH-THE-NEEDLE MICROFORCEPS BIOPSY IF REQUIRED FOR PATIENTS WITH INDETERMINATE PANCREATIC CYSTIC LESIONS

Pancreatic cancer clinical (Posters)  et al.

UTILITY OF HISTOPATHOLOGICAL REVISION IN THE MANAGEMENT OF GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASIA
UTILITY OF HISTOPATHOLOGICAL REVISION IN THE MANAGEMENT OF GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASIA

Pancreatic cancer clinical (Posters)  et al.

PANCREATIC CANCER SCREENING IN HIGH-RISK INDIVIDUALS
PANCREATIC CANCER SCREENING IN HIGH-RISK INDIVIDUALS

Pancreatic cancer clinical (Posters)  et al.

CHANGES OF ORAL AND DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE POSSIBLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS
CHANGES OF ORAL AND DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE POSSIBLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS

Pancreatic cancer clinical (Posters)  et al.

PREDICTIONS AND PREVENTING OF POSTOPERATIVE PANCREATIC FISTULA IN PATIENTS FOLLOWING PANCREATICODUODENECTOMY
PREDICTIONS AND PREVENTING OF POSTOPERATIVE PANCREATIC FISTULA IN PATIENTS FOLLOWING PANCREATICODUODENECTOMY

Pancreatic cancer clinical (Posters)  et al.

Item 1 - 18 / 18
1